Azobenzene-Grafted Acrylate Coatings to Modulate Lens Epithelial Cells
Source abstract
Abstract
Polymeric intraocular lenses (IOLs) are prosthetics used to replace cataracts to restore vision. However, in 20% or more of cases, lens epithelial cells (LECs) remaining after surgery migrate along the IOL and posterior capsule, causing new vision anomalies, termed posterior capsule opacification (PCO). The surface of the polymeric IOL is identified as a leading factor for the development of their failure, and we hypothesize that specialized coatings could mitigate or prevent these failures. Azobenzene was grafted to coatings made of poly(methacrylic acid- co -isodecyl acrylate) (MAAcoIDA) and poly(methyl methacrylate- co -isodecyl acrylate) (MMcoIDA) to produce a library of acrylic coatings. The azobenzene on the surface of these coatings could reversibly photoisomerize with 365 nm light and complex with β-cyclodextrin (β-CD). Human LEC cell line, B3-LECs, grown on these coatings had modulated protein and gene expression, with lower α-smooth muscle actin protein expression and inflammatory interleukin 6 gene expression in cells incubated on all of the variations of MMcoIDA compared to MAAcoIDA. Azobenzene modifications with and without UV and β-CD treatment also modulated cell behavior where cells on azobenzene-modified MAAcoIDA had decreased live/dead ratios after UV treatments, a potential method to reduce LEC viability. The cells on β-CD-treated azobenzene-modified MAAcoIDA had differences in cell adhesion after UV treatments, illustrating that UV light can be applied to modulate cell behavior in conjunction with β-CD. The different coatings present methods to modulate LEC adhesion, death, and behavior, temporarily when dependent on UV treatments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Intraocular Surgery and Lenses · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering
Queen’s University
Funding
Ontario Ministry of Research and Innovation · Natural Sciences and Engineering Research Council of Canada · Queen's University · Government of Ontario
References (85)
Show source-provided references
1. Blindness, G. B. D.; Vision Impairment, C.; Vision Loss Expert Group of the Global Burden of Disease, S. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 2021; Vol. 9 2, pp e144–e160.
2. Taylor, H. R.Epidemiology of age-related cataract. Eye (Lond) 1999; Vol. 13 Pt 3b, pp 445–448.10.1038/eye.1999.119 ↗
3. 10.1016/j.ajo.2021.02.03210.1016/j.ajo.2021.02.032 ↗
4. 10.1038/s41433-020-0806-310.1038/s41433-020-0806-3 ↗
5. Vision 2020: the cataract challenge Community Eye Health 2000; Vol. 13 34, pp 17–19.
6. 10.1016/j.addr.2018.03.00910.1016/j.addr.2018.03.009 ↗
7. 10.1038/s41433-019-0630-910.1038/s41433-019-0630-9 ↗
8. 10.1016/j.preteyeres.2020.10090510.1016/j.preteyeres.2020.100905 ↗
9. Karahan E. · Med. Hypothesis, Discovery Innovation Ophthalmol. · 2014 · 3 · 45
10. 10.1186/s12916-014-0181-710.1186/s12916-014-0181-7 ↗
11. 10.1016/S0886-3350(00)00748-310.1016/S0886-3350(00)00748-3 ↗
12. 10.1177/088532821663854710.1177/0885328216638547 ↗
13. 10.1371/journal.pone.011497310.1371/journal.pone.0114973 ↗
14. 10.1038/s41570-021-00334-w10.1038/s41570-021-00334-w ↗
15. 10.1016/j.jphotochemrev.2012.06.00210.1016/j.jphotochemrev.2012.06.002 ↗
16. 10.1002/cptc.20210008510.1002/cptc.202100085 ↗
17. 10.1007/s10953-010-9639-110.1007/s10953-010-9639-1 ↗
18. 10.1021/acsami.6b0973410.1021/acsami.6b09734 ↗
19. 10.1039/C4BM00159A10.1039/C4BM00159A ↗
20. 10.1088/1748-605X/acbc0010.1088/1748-605X/acbc00 ↗
21. 10.1002/adhm.20190066710.1002/adhm.201900667 ↗
22. 10.1016/j.biomaterials.2020.12049910.1016/j.biomaterials.2020.120499 ↗
23. 10.1016/j.biomaterials.2017.03.03210.1016/j.biomaterials.2017.03.032 ↗
24. 10.1016/j.biomaterials.2021.12134210.1016/j.biomaterials.2021.121342 ↗
25. 10.1002/jbm.a.3753710.1002/jbm.a.37537 ↗
26. 10.1039/C4BM00159A10.1039/C4BM00159A ↗
27. 10.1007/s10853-022-07264-y10.1007/s10853-022-07264-y ↗
28. Clarke A. E. · 2017
29. 10.1021/acs.bioconjchem.7b0080210.1021/acs.bioconjchem.7b00802 ↗
30. 10.3928/1081597X-20210310-0110.3928/1081597X-20210310-01 ↗
31. General Method for Measuring Cytotoxicity or Proliferation Using alamarBlue. https://www.bio-rad-antibodies.com/measuring-cytotoxicity-proliferation-spectrophotometry-fluorescence-alamarblue.html.
32. 10.1016/j.exer.2018.03.01310.1016/j.exer.2018.03.013 ↗
33. 10.1002/iid3.9010.1002/iid3.90 ↗
34. 10.1042/BCJ2019054010.1042/BCJ20190540 ↗
35. 10.1186/s12886-022-02691-610.1186/s12886-022-02691-6 ↗
36. 10.1038/cddiscovery.2016.2010.1038/cddiscovery.2016.20 ↗
37. 10.1167/iovs.07-058610.1167/iovs.07-0586 ↗
38. 10.1016/j.tibtech.2018.12.00210.1016/j.tibtech.2018.12.002 ↗
39. 10.1105/tpc.109.06600110.1105/tpc.109.066001 ↗
40. 10.1021/ja00016a06310.1021/ja00016a063 ↗
41. 10.1021/jz402762h10.1021/jz402762h ↗
42. 10.1016/j.ajo.2006.11.04510.1016/j.ajo.2006.11.045 ↗
43. 10.1097/MD.000000000000830110.1097/MD.0000000000008301 ↗
44. 10.1088/1361-648X/aa7ca710.1088/1361-648X/aa7ca7 ↗
45. 10.1351/PAC-CON-10-09-0410.1351/PAC-CON-10-09-04 ↗
46. 10.1111/php.1268610.1111/php.12686 ↗
47. 10.1039/c3pp25408a10.1039/c3pp25408a ↗
48. 10.1039/c0sm00043d10.1039/c0sm00043d ↗
49. 10.1038/ncomms161710.1038/ncomms1617 ↗
50. 10.1021/acs.langmuir.2c0300410.1021/acs.langmuir.2c03004 ↗
51. 10.1038/ncomms1308810.1038/ncomms13088 ↗
52. 10.1016/j.carres.2008.05.01610.1016/j.carres.2008.05.016 ↗
53. 10.1007/s10973-016-5736-810.1007/s10973-016-5736-8 ↗
54. 10.3980/j.issn.2222-3959.2010.02.1110.3980/j.issn.2222-3959.2010.02.11 ↗
55. Pettit D. K. · Invest. Ophthalmol. Visual Sci. · 1990 · 31 · 2269
56. 10.1021/la960434110.1021/la9604341 ↗
57. 10.1021/ja00183a04910.1021/ja00183a049 ↗
58. Lovicu, F. J.; Schulz, M. W.; Hales, A. M.; Vincent, L. N.; Overbeek, P. A.; Chamberlain, C. G.; McAvoy, J. W. TGFβ induces morphological and molecular changes similar to human anterior subcapsular cataract Br. J. Ophthalmol. 2002; Vol. 86 210.1136/bjo.86.2.220.10.1136/bjo.86.2.220 ↗
59. 10.1016/j.exer.2015.03.01110.1016/j.exer.2015.03.011 ↗
60. 10.1016/S0021-5155(98)00033-110.1016/S0021-5155(98)00033-1 ↗
61. Wormstone I. M. · Invest. Ophthalmol. Visual Sci. · 2002 · 43 · 2301
62. Kandhwal M. · Am. J. Transl Res. · 2022 · 14 · 4391
63. 10.1002/path.227710.1002/path.2277 ↗
64. 10.1038/sj.eye.670273510.1038/sj.eye.6702735 ↗
65. 10.1091/mbc.e06-05-041610.1091/mbc.e06-05-0416 ↗
66. 10.1016/S0006-291X(89)80215-310.1016/S0006-291X(89)80215-3 ↗
67. 10.1002/pro.222910.1002/pro.2229 ↗
68. 10.1016/S1350-9462(98)00027-510.1016/S1350-9462(98)00027-5 ↗
69. 10.1038/eye.1999.11410.1038/eye.1999.114 ↗
70. 10.1042/BCJ2016012810.1042/BCJ20160128 ↗
71. 10.1016/S0886-3350(96)80174-X10.1016/S0886-3350(96)80174-X ↗
72. 10.1016/j.mehy.2012.12.04210.1016/j.mehy.2012.12.042 ↗
73. 10.1016/S1074-7613(00)80334-910.1016/S1074-7613(00)80334-9 ↗
74. 10.1097/ICU.0b013e3282f2013210.1097/ICU.0b013e3282f20132 ↗
75. 10.1039/c3sm50220a10.1039/c3sm50220a ↗
76. 10.1167/iovs.10-553110.1167/iovs.10-5531 ↗
77. 10.1046/j.1525-1594.2001.025006453.x10.1046/j.1525-1594.2001.025006453.x ↗
78. 10.1016/j.jcrs.2009.05.05210.1016/j.jcrs.2009.05.052 ↗
79. 10.1016/S0886-3350(99)00137-610.1016/S0886-3350(99)00137-6 ↗
80. Olivero D. K. · Invest. Ophthalmol. Visual Sci. · 1993 · 34 · 2825
81. 10.1016/S0092-8674(02)00971-610.1016/S0092-8674(02)00971-6 ↗
82. 10.1074/jbc.M10201420010.1074/jbc.M102014200 ↗
83. 10.1088/1748-605X/acbc0010.1088/1748-605X/acbc00 ↗
84. 10.1016/j.biomaterials.2003.09.06910.1016/j.biomaterials.2003.09.069 ↗
85. 10.1039/a705098d10.1039/a705098d ↗